dy2594 05 Search Results


human gfap duoset elisa  (R&D Systems)
93
R&D Systems human gfap duoset elisa
Human Gfap Duoset Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dy2594+05/Human+GFAP+DuoSet+ELISA/pmc10827333-124-47-45
Average 93 stars, based on 1 article reviews
human gfap duoset elisa - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
gfap  (R&D Systems)
94
R&D Systems gfap
FIGURE 7. This line graph shows a comparison of astroglial protein (solid lines) and the corresponding autoantibody levels (dotted line). Two-year follow-up of the five TBI patients is shown for each measured profile where the order of individuals is maintained for easy comparison (Baseline—TBI-0; follow-up year-1 (TBI-1); year-2 (TBI-2). Although this is not a continuous data, the line graph allows us to follow the trend among individual subjects. The astroglial <t>marker</t> <t>S100B</t> (S100 calcium binding protein B) is shown in red solid line and the S100B autoantibodies in red dotted line; <t>GFAP</t> plasma protein is in blue solid line and the GFAP autoantibodies is in blue dotted line.
Gfap, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dy2594+05/Human+GFAP+DuoSet+ELISA/pm32074362-79-16-25
Average 94 stars, based on 1 article reviews
gfap - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


FIGURE 7. This line graph shows a comparison of astroglial protein (solid lines) and the corresponding autoantibody levels (dotted line). Two-year follow-up of the five TBI patients is shown for each measured profile where the order of individuals is maintained for easy comparison (Baseline—TBI-0; follow-up year-1 (TBI-1); year-2 (TBI-2). Although this is not a continuous data, the line graph allows us to follow the trend among individual subjects. The astroglial marker S100B (S100 calcium binding protein B) is shown in red solid line and the S100B autoantibodies in red dotted line; GFAP plasma protein is in blue solid line and the GFAP autoantibodies is in blue dotted line.

Journal: Military medicine

Article Title: Monitoring from Battlefield to Bedside: Serum Repositories Help Identify Biomarkers, Perspectives on Mild Traumatic Brain Injury.

doi: 10.1093/milmed/usz301

Figure Lengend Snippet: FIGURE 7. This line graph shows a comparison of astroglial protein (solid lines) and the corresponding autoantibody levels (dotted line). Two-year follow-up of the five TBI patients is shown for each measured profile where the order of individuals is maintained for easy comparison (Baseline—TBI-0; follow-up year-1 (TBI-1); year-2 (TBI-2). Although this is not a continuous data, the line graph allows us to follow the trend among individual subjects. The astroglial marker S100B (S100 calcium binding protein B) is shown in red solid line and the S100B autoantibodies in red dotted line; GFAP plasma protein is in blue solid line and the GFAP autoantibodies is in blue dotted line.

Article Snippet: Platelet-activating factor/PF4 (cat# DPF40), BDNF (Cat# DBD00), NGF-β (Cat#DY256), TNF-α (DTA00D), IL-6 (D6050), S100B (DY1820–05), and GFAP (DY2594–05) were done based on the manufacturer’s protocol (R&D systems, USA).

Techniques: Comparison, Marker, Binding Assay, Clinical Proteomics

FIGURE 6. Neuroglia protein in the plasma is an indication of neural injury. The plasma level of S100B (S100 calcium binding protein B) spikes immediately after injury (TBI-0) (∗p < 0.0001). This protein is mainly seen in astrocytes and is known to regulate calcium influx and interact with other proteins. The S100B level appears to decrease over the years; on the contrary, the glial cell marker GFAP gradually seemed to increase in year-1 (TBI-1) and year-2 (TBI-2) (∗p < 0.0001).

Journal: Military medicine

Article Title: Monitoring from Battlefield to Bedside: Serum Repositories Help Identify Biomarkers, Perspectives on Mild Traumatic Brain Injury.

doi: 10.1093/milmed/usz301

Figure Lengend Snippet: FIGURE 6. Neuroglia protein in the plasma is an indication of neural injury. The plasma level of S100B (S100 calcium binding protein B) spikes immediately after injury (TBI-0) (∗p < 0.0001). This protein is mainly seen in astrocytes and is known to regulate calcium influx and interact with other proteins. The S100B level appears to decrease over the years; on the contrary, the glial cell marker GFAP gradually seemed to increase in year-1 (TBI-1) and year-2 (TBI-2) (∗p < 0.0001).

Article Snippet: Platelet-activating factor/PF4 (cat# DPF40), BDNF (Cat# DBD00), NGF-β (Cat#DY256), TNF-α (DTA00D), IL-6 (D6050), S100B (DY1820–05), and GFAP (DY2594–05) were done based on the manufacturer’s protocol (R&D systems, USA).

Techniques: Clinical Proteomics, Binding Assay, Marker